The Laws of the Pharmaceutical Industry - Dr. Matthias Rath

[Guest guest]

SSRI-Research@

Sat, 15 Apr 2006 21:53:14 -0400

[sSRI-Research] The Laws of the Pharmaceutical Industry - Dr.

Matthias Rath

 

 

 

 

The Laws of the Pharmaceutical Industry

 

The main principles governing the pharmaceutical " business with

disease. " It is not in the financial interests of the pharmaceutical

industry to prevent common diseases - the maintenance and expansion of

diseases is a precondition for the financial growth of this industry.

 

1

The pharmaceutical industry is an investment industry driven by the

profits of its shareholders. Improving human health is not the driving

force of this industry.

 

2

The pharmaceutical investment industry was artificially created and

strategically developed over an entire century by the same investment

groups that control the global petrochemical and chemical industries.

 

3

The huge profits of the pharmaceutical industry are based on the

patenting of new drugs. These patents essentially allow drug

manufacturers to arbitrarily define the profits for their products.

 

4

The marketplace for the pharmaceutical industry is the human body -

but only for as long as the body hosts diseases. Thus, maintaining and

expanding diseases is a precondition for the growth of the

pharmaceutical industry.

 

5

A key strategy to accomplish this goal is the development of drugs

that merely mask symptoms while avoiding the curing or elimination of

diseases. This explains why most prescription drugs marketed today

have no proven efficacy and merely target symptoms.

 

6

To further expand their pharmaceutical market, the drug companies are

continuously looking for new applications (indications) for the use of

drugs they already market. For example, Bayer's pain pill Aspirin is

now taken by 50 million healthy US citizens under the illusion it will

prevent heart attacks.

 

7

Another key strategy to expand pharmaceutical markets is to cause new

diseases with drugs. While merely masking symptoms short term, most of

the prescription drugs taken by millions of patients today cause a

multitude of new diseases as a result of their known long-term side

effects. For example, all cholesterol-lowering drugs currently on the

market are known to increase the risk of developing cancer - but only

after the patient has been taking the drug for several years.

 

8

The known deadly side effects of prescription drugs are the fourth

leading cause of death in the industrialized world, surpassed only by

the number of deaths from heart attacks, cancer and strokes (Journal

of the American Medical Association, April 15, 1998). This fact is no

surprise either, because drug patents are primarily issued for new

synthetic molecules. All synthetic molecules need to be detoxified and

eliminated from the body, a system that frequently fails and results

in an epidemic of severe and deadly side effects.

 

 

9

While the promotion and expansion of diseases increase the market of

the pharmaceutical investment industry - prevention and root cause

treatment of diseases decrease long-term profitability; therefore,

they are avoided or even obstructed by this industry.

 

10

Worst of all, the eradication of diseases is by its very nature

incompatible with and diametrically opposed to the interests of the

pharmaceutical investment industry. The eradication of diseases now

considered as potential drug markets will destroy billions of

investment dollars and eventually will eliminate this entire industry.

 

11

Vitamins and other effective natural health therapies that optimize

cellular metabolism threaten the pharmaceutical " business with

disease " because they target the cellular cause of today's most common

diseases - and these natural substances cannot be patented.

 

12

Throughout the more than one hundred year existence of the

pharmaceutical industry, vitamins and other essential nutrients, with

defined functions as cofactors in cellular metabolism, have been the

fiercest competition and the greatest threat to the long-term success

of the pharmaceutical investment business.

 

13

Vitamins and other effective natural health therapies that effectively

prevent diseases are incompatible with the very nature of the

pharmaceutical " business with disease. "

 

14

To protect the strategic development of its investment business

against the threat from effective, natural and non-patentable

therapies, the pharmaceutical industry has - over an entire century -

used the most unscrupulous methods, such as:

 

 

(1) Withholding life-saving health information from millions of

people. It is simply unacceptable that today so few know that the

human body cannot produce vitamin C and lysine, two key molecules for

connective tissue stability and disease prevention.

 

 

(2) Discrediting natural health therapies. The most common way is

through global PR campaigns organized by the Pharma-Cartel that spread

lies about the alleged side effects of natural substances - molecules

that have been used by Nature for millennia.

 

 

(3) Banning by law the dissemination of information about natural

health therapies. To that end, the pharmaceutical industry has placed

its lobbyists in key political positions in key markets and leading

drug export nations.

 

 

 

15

The pharmaceutical " business with disease " is the largest deception

and fraud business in human history. The product " health " promised by

drug companies is not delivered to millions of patients. Instead, the

" products " most often delivered are the opposite: new diseases and

frequently, death.

 

16

The survival of the pharmaceutical industry is dependent on the

elimination by any means of effective natural health therapies. These

natural and non-patentable therapies have become the treatment of

choice for millions of people despite the combined economic, political

and media opposition of the world's largest investment industry.

 

http://www4.dr-rath-foundation.org/PHARMACEUTICAL_BUSINESS/laws_of_the_pharmaceu\

tical_industry.htm